Clinical Focus

• Cardiology (Heart)
• Cardiovascular Medicine
• Heart and Lung Transplantation
• Heart Failure
• Cardiomyopathy

Administrative Appointments

• Medical Director, CardiomyopathyCenter, Stanford University Medical Center (2001 - present)
• Director, Heart Failure Program, Stanford University Medical Center (2001 - present)
• Professor of Medicine, CardiovascularMedicine, Stanford University Medical Center (1999 - present)
• Assoc. Prof. of Medicine, CardiovascularMedicine, Stanford University Medical Center (1993 - 1999)
• Co-Director, Heart Failure Clinic, Stanford University Medical Center (1991 - 2001)

Professional Education

Current Research Interests

Adrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.

Clinical Trials

• Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients with Heart Failure Recruiting

Publications

• Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy. Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D. Echocardiography. 2009; 26 (7): 759-65
• Hypertension, heart failure, and beta-adrenergic blocking drugs. Fowler MB, J Am Coll Cardiol. 2008; 52 (13): 1073-5
• Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. Witteles RM, Fowler MB. J Am Coll Cardiol. 2008; 51 (2): 93-102
• Beta-blocker dosing in community-based treatment of heart failure. Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie BM, Abraham WT, Franciosa JA. Am Heart J. 2007; 153 (6): 1029-36
• Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB. J Am Coll Cardiol. 2007; 50 (19): 1835-40